KRAS and cancer: The pivotal hub genes (mainly PPARG, PTGS2, PTPRC, CDKN2A, and PRKACB) and lncRNAs (e.g., OGFRL1, DGCR5, and LINC01842) have been previously reported to have critical roles in the tumorigenesis of many cancers harboring KRAS mutation.